Take It Down a NOTCH in Forebrain Tumors

Barbara Oldrini1, Alberto J Schuhmacher1, Massimo Squatrito1

  • 1Cancer Cell Biology Programme, Seve Ballesteros Foundation Brain Tumor Group, Centro Nacional de Investigaciones Oncológicas, CNIO, 28029 Madrid, Spain.

Cancer Cell
|December 19, 2015
PubMed

Insights

Notch signaling acts as a tumor suppressor in brain tumors. Decreased Notch activity may drive the development of supratentorial primitive neuroectodermal tumors (sPNET).

Area of Science:

  • Neuro-oncology
  • Molecular oncology
  • Cancer genetics

Background:

  • Supratentorial primitive neuroectodermal tumors (sPNET) are aggressive brain cancers.
  • The molecular drivers of sPNET development remain incompletely understood.
  • Notch signaling is a crucial pathway in development and cancer, with context-dependent roles.

Purpose of the Study:

  • To investigate the role of Notch signaling in the development of forebrain tumors.
  • To determine if Notch signaling functions as a tumor suppressor in this context.
  • To explore the potential involvement of altered Notch activity in sPNET pathogenesis.

Main Methods:

  • Utilized various experimental approaches including genetic manipulation and molecular analyses.
  • Investigated Notch signaling pathway components and their activity in tumor models.
  • Analyzed patient-derived samples to correlate Notch activity with tumor characteristics.

Main Results:

  • Demonstrated a tumor suppressor function for Notch signaling in forebrain tumors.
  • Identified decreased Notch activity in a subset of supratentorial primitive neuroectodermal tumors.
  • Provided evidence linking reduced Notch signaling to sPNET development.

Conclusions:

  • Notch signaling plays a critical role in suppressing forebrain tumor formation.
  • Reduced Notch pathway activity is a potential key molecular event in the pathogenesis of sPNET.
  • Targeting Notch signaling may offer therapeutic strategies for these challenging brain tumors.